{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:11:35Z","timestamp":1789690295662,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.pdpdt.2025.105286","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T15:15:09Z","timestamp":1763651709000},"page":"105286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluating the Impact of Febuxostat on 5-Aminolevulinic Acid-Based Photodynamic Therapy in Bladder Cancer Cell Lines"],"prefix":"10.1016","volume":"56","author":[{"given":"Fatemeh","family":"Khatami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Sharifkazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman Menbari","family":"Oskouie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahil","family":"Mashhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parsa","family":"Nikoofar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad Kazem","family":"Aghamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pdpdt.2025.105286_bib0001","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.pdpdt.2025.105286_bib0002","article-title":"Bladder cancer: current challenges and future directions","volume":"57","author":"Dobruch","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.pdpdt.2025.105286_bib0003","doi-asserted-by":"crossref","unstructured":"Hinotsu S, Akaza H, Naito S, Ozono S, Sumiyoshi Y, Noguchi S, et al. Maintenance therapy with bacillus Calmette-Gu\u00e9rin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer. 2011;108(2):187\u201395.","DOI":"10.1111\/j.1464-410X.2010.09891.x"},{"issue":"1","key":"10.1016\/j.pdpdt.2025.105286_bib0004","first-page":"36","article-title":"Age limit of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in correlation of bladder cancer tumor stage and grade","volume":"6","author":"Ahmadi","year":"2024","journal-title":"Translat. Res. Urol"},{"issue":"4","key":"10.1016\/j.pdpdt.2025.105286_bib0005","first-page":"184","article-title":"Prognostic value of androgen receptor expression in bladder tumors","volume":"5","author":"Soltani","year":"2023","journal-title":"Translat. Res. Urol"},{"issue":"24","key":"10.1016\/j.pdpdt.2025.105286_bib0006","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.3390\/cancers16244125","article-title":"Comparisons of intravesical treatments with Mitomycin C, Gemcitabine, and Docetaxel for recurrence and progression of non-muscle invasive bladder cancer: updated systematic review and meta-analysis","volume":"16","author":"Matloubieh","year":"2024","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.pdpdt.2025.105286_bib0007","doi-asserted-by":"crossref","unstructured":"Jiang W, Liang M, Lei Q, Li G, Wu SJC. The current status of photodynamic therapy in cancer treatment. 2023;15(3):585.","DOI":"10.3390\/cancers15030585"},{"issue":"2","key":"10.1016\/j.pdpdt.2025.105286_bib0008","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/iju.13291","article-title":"5-Aminolevulinic acid-mediated photodynamic therapy for bladder cancer","volume":"24","author":"Inoue","year":"2017","journal-title":"Int. J. Urol."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.105286_bib0009","first-page":"5778","article-title":"An overview on preclinical and clinical experiences with photodynamic therapy for bladder cancer","volume":"18","author":"Yavari","year":"2011","journal-title":"Can. J. Urol."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.105286_bib0010","first-page":"250","article-title":"Photodynamic therapy of cancer: an update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.pdpdt.2025.105286_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2021.102340","article-title":"Chinese guidelines on the clinical application of 5-aminolevulinic acid-based photodynamic therapy in dermatology (2021 edition)","volume":"35","author":"Shi","year":"2021","journal-title":"Photodiagnosis. Photodyn. Ther."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.105286_bib0012","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s11060-019-03103-4","article-title":"5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas","volume":"141","author":"Mahmoudi","year":"2019","journal-title":"J. Neurooncol."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.105286_bib0013","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.pdpdt.2011.12.004","article-title":"Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro","volume":"9","author":"Hagiya","year":"2012","journal-title":"Photodiagnosis. Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2025.105286_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2019.10.014","article-title":"The role of ABCG2 in modulating responses to anti-cancer photodynamic therapy","volume":"29","author":"Khot","year":"2020","journal-title":"Photodiagnosis. Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2025.105286_bib0015","doi-asserted-by":"crossref","unstructured":"Khot MI, Perry SL, Maisey T, Armstrong G, Andrew H, Hughes TA, et al. Inhibiting ABCG2 could potentially enhance the efficacy of hypericin-mediated photodynamic therapy in spheroidal cell models of colorectal cancer. 2018;23:221\u20139.","DOI":"10.1016\/j.pdpdt.2018.06.027"},{"key":"10.1016\/j.pdpdt.2025.105286_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00518","article-title":"Identification of Febuxostat as a new strong ABCG2 inhibitor: potential applications and risks in clinical situations","volume":"7","author":"Miyata","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pdpdt.2025.105286_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00208","article-title":"Inhibitors of Human ABCG2: from technical background to recent updates with clinical implications","volume":"10","author":"Toyoda","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.105286_bib0018","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40265-015-0360-7","article-title":"Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout","volume":"75","author":"Frampton","year":"2015","journal-title":"Drugs"},{"issue":"138","key":"10.1016\/j.pdpdt.2025.105286_bib0019","article-title":"An In vitro approach to photodynamic therapy","author":"Au - Austin","year":"2018","journal-title":"JoVE."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.105286_bib0020","first-page":"54","article-title":"CAR T cell therapy: A new weapon to fight bladder cancer","volume":"4","author":"Deyhimfar","year":"2022","journal-title":"Translat. Res. Urol"},{"key":"10.1016\/j.pdpdt.2025.105286_bib0021","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jphotobiol.2013.07.003","article-title":"Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition","volume":"126","author":"Barron","year":"2013","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.pdpdt.2025.105286_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2021.102452","article-title":"Predictors of therapeutic efficacy of 5-aminolevulinic acid-based photodynamic therapy in human prostate cancer","volume":"35","author":"Yamamoto","year":"2021","journal-title":"Photodiagnosis. Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2025.105286_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2023.103581","article-title":"Cell senescence-associated porphyrin metabolism affects the efficacy of aminolevulinic acid-photodynamic diagnosis in bladder cancer","volume":"42","author":"Lai","year":"2023","journal-title":"Photodiagnosis. Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2025.105286_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2020.112017","article-title":"Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells","volume":"211","author":"Howley","year":"2020","journal-title":"J. Photochem. Photobiol. B"},{"issue":"9","key":"10.1016\/j.pdpdt.2025.105286_bib0025","article-title":"Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines","volume":"26","author":"Pratheeba","year":"2021","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.pdpdt.2025.105286_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115031","article-title":"Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines","volume":"200","author":"Mansi","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.pdpdt.2025.105286_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci8120203","article-title":"Augmentation of 5-aminolevulinic acid treatment of glioblastoma by adding ciprofloxacin, Deferiprone, 5-fluorouracil and febuxostat: the CAALA regimen","volume":"8","author":"Kast","year":"2018","journal-title":"Brain Sci."},{"issue":"5","key":"10.1016\/j.pdpdt.2025.105286_bib0028","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1021\/acs.bioconjchem.9b00191","article-title":"Molecular tools to generate reactive oxygen species in biological systems","volume":"30","author":"Xiong","year":"2019","journal-title":"Bioconjug. Chem."},{"issue":"13","key":"10.1016\/j.pdpdt.2025.105286_bib0029","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular safety of Febuxostat or Allopurinol in patients with gout","volume":"378","author":"White","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.pdpdt.2025.105286_bib0030","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3899\/jrheum.080814","article-title":"Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout","volume":"36","author":"Becker","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.pdpdt.2025.105286_bib0031","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jddst.2017.04.020","article-title":"Transdermal potential and anti-gout efficacy of Febuxostat from niosomal gel","volume":"39","author":"Singh","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100025008178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100025008178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:39:16Z","timestamp":1789688356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100025008178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"alternative-id":["S1572100025008178"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2025.105286","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the Impact of Febuxostat on 5-Aminolevulinic Acid-Based Photodynamic Therapy in Bladder Cancer Cell Lines","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2025.105286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105286"}}